John Yianni

John Yianni is the CEO of CryoTherapeutics SA, where John utilizes cryotherapy for the treatment and prevention of heart attacks. John is also a partner at Earlybird Venture Capital, investing in new technology ventures in the medical field in Europe. Prior to their current roles, John was the founder and board member of Reverse Medical Corp, an endovascular technology company that was later acquired by Covidien. With a background in biophysics and a PhD from the University of Salford, John has a history of leadership in various companies focused on medical innovations.